Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elastin is a highly elastic extracellular matrix protein encoded by the *ELN* gene, which allows tissues in vertebrates—especially arteries, lungs, and skin—to resume their shape after stretching or contracting. Its precursor, tropoelastin, is a soluble monomer composed chiefly of non-polar amino acids (glycine, valine, proline, alanine), interspersed with cross-linking domains rich in lysine. The synthesis and assembly of elastin involve the enzymatic action of lysyl oxidase, which cross-links tropoelastin into durable, insoluble fibers. Amino acid support refers to providing these specific residues necessary for effective synthesis and cross-linking. Stimulation of elastin synthesis—sometimes considered for anti-aging or vascular therapies—can be achieved pharmacologically (e.g., minoxidil) or potentially by supplementing amino acids critical for elastin/tropoelastin structure. However, "elastin synthesis stimulation via amino acid support" itself is not a discrete molecular entity. Summary: The phrase describes a biological pathway/process, not a canonical drug target. Therapeutically, efforts focus on upregulation of ELN/tropoelastin or modulation of enzymes (e.g., lysyl oxidase) that govern elastin assembly. The protein elastin’s formation and function are heavily dependent on the supply of certain amino acids and regulatory factors.
Minoxidil increases ELN gene expression via Ca²⁺-ERK-dependent pathways in fibroblasts and smooth muscle cells. Exogenous elastin-derived peptides interact with elastin receptors (ERC) and integrins, potentially stimulating endogenous elastin production via IGF-1 receptor pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elastin (precursor: Tropoelastin) (ELN (gene); no standard protein-level abbreviation).